Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-07-18

Clinical Trial Update: Protocol Establishment for the Prevention of Lamotrigine-induced Skin Rash in Epilepsy Patients [Phase 2]

View source ↗

Summary

This document describes a Phase 2 trial protocol to prevent lamotrigine-induced skin rash in patients with epilepsy. The study is being developed by Seoul Natio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamotrigine (lamotrigine)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Lamotrigine Allergy | Phase 2 | Status: UNKNOWN